Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Injectable Weight Loss Medications Weight loss isnt just about willpowerits about biology
Recently, the newly developed drug tirzepatide, which targets both the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, was introduced to the market to treat type 2 diabetes and obesity in 2022 and 2023, respectively (Table 1)
Patient experiences show that cost, tolerability, lifestyle, and personal goals all influence whether they continue, taper, cycle, or stop altogether
The currently approved and available weight loss injectable treatments in the UK include semaglutide 2.4mg (Wegovy, by Novo Nordisk) and tirzepatide (Mounjaro, by Eli Lilly)
US$ 23.56
US$ 27.91
US$ 26.97
US$ 28.17
US$ 24.33
